BenevolentAI
proprietary knowledge graph purpose built for drug discovery the data engine that powers the benevolent platform comprehensive data diversity of data growth of data literature literature patent literature regulatory documents pathology diseases symptoms biological systems cellular component molecular function biological process mechanism pathways benevolent knowledge graph assay data binding comparison screens clinical trial genes proteins transcripts variants molecules organic compounds preclinical candidates approved drugs antibodies other pharmacology uniquely combines public proprietary inferred knowledge of the most important information used by our models is derived proprietary knowledge therapeutic area and drug modality agnostic can be deployed with partners in secure cloud environment | BenevolentAI
Company
Deck Type
Deck date
December 2021
Slide
13 of 42
Related slides by other companies
Market
April 2023
Results
March 2024
SPAC
June 2021
SPAC
April 2021
Other recent decks by BenevolentAI
Results
March 2024
Investor Conference
January 2024
Investor Presentation
May 2023
Results
March 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io